שווי פעילות לרווח לפני ריבית, מסים ופחת Ocean Biomedical (OCEA)

Ocean Biomedical, Inc. (OCEA) is integrating ESG principles into the development of immune therapies, strictly adhering to bioethics and environmental safety. Management is focused on the commercial advancement of cutting-edge medical technologies in oncology. This EV/EBITDA price action chart on GURU.Markets captured a value of . Independence from global economic fluctuations and sustained interest in biopharmaceuticals make the asset a reliable defensive tool over the long term.

Ocean Biomedical, Inc. (OCEA) employs a strategy of diversifying R&D risks through university collaborations, which necessitates strict control over its debt load. The EV/EBITDA metric measures the total enterprise value relative to operating profit before depreciation and amortization, revealing the model's resilience to cost inflation. By analyzing this EV/EBITDA chart, an investor can determine the asset's degree of overvaluation and the company's margin of safety amid high credit pressure.